title: Global Advisory Committee on Vaccine Safety,12–13 June 2013.
mesh_terms: D019433:Chickenpox Vaccine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D014943:Global Health; D018073:Haemophilus Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007252:Influenza Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D022321:Japanese Encephalitis Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D009290:Narcolepsy / Q000209:etiology; D053918:Papillomavirus Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D012449:Safety; D014611:Vaccination / Q000009:adverse effects*; D014612:Vaccines / Q000009:adverse effects* / Q000627:therapeutic use*; D014944:World Health Organization; D022341:Yellow Fever Vaccine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D019433:Chickenpox Vaccine; D018073:Haemophilus Vaccines; D007252:Influenza Vaccines; D022321:Japanese Encephalitis Vaccines; D053918:Papillomavirus Vaccines; D014612:Vaccines; D022341:Yellow Fever Vaccine